Methods for Treating Lysosomal Acid Lipase Deficiency in Patients
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 61/403,011, filed Sep 9, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,166,274 | Methods for Treating Lysosomal Acid Lipase Deficiency in Patients In force · Medium confidence UsedRemaining | Alexion Pharmaceuticals, Inc. | In force | Medium confidence | ||
| US 10,407,671 | Lysosomal Storage Disease Enzymes In force · High confidence | Alexion Pharmaceuticals, Inc. | In force | High confidence | ||
| US 10,858,638 | Lysosomal Storage Disease Enzymes In force · High confidence | Alexion Pharma LLC | In force | High confidence | ||
| US 11,560,554 | Lysosomal Storage Disease Enzymes In force · High confidence | Alexion Pharmaceuticals, Inc. | In force | High confidence | ||
| US 12,076,376 | Methods for Treating Lysosomal Acid Lipase Deficiency in Patients In force · Low confidence | Alexion Pharmaceuticals, Inc. | In force | Low confidence | ||
| US 11,400,141 | Methods for Treating Lysosomal Acid Lipase Deficiency in Patients In force · Low confidence | Alexion Pharmaceuticals, Inc. | In force | Low confidence | ||
| Application 13/642,790 | Lysosomal Storage Disease Enzymes Abandoned Abandoned Jan 25, 2017 | Alexion Pharmaceuticals, Inc. | Abandoned | Abandoned Jan 25, 2017 | ||
| Application 14/491,604 | Lysosomal Storage Disease Enzyme Abandoned Abandoned Jul 22, 2016 | Alexion Pharmaceuticals, Inc. | Abandoned | Abandoned Jul 22, 2016 | ||
| Application 15/177,867 | Lysosomal Storage Disease Enzymes Abandoned Abandoned Oct 6, 2016 | Alexion Pharmaceuticals, Inc. | Abandoned | Abandoned Oct 6, 2016 | ||
| Application 15/285,025 | Lysosomal Storage Disease Enzymes Abandoned Abandoned Feb 14, 2017 | Synageva Biopharma Corp. | Abandoned | Abandoned Feb 14, 2017 | ||
| 1 more record in this group · Pro | ||||||
10 of 11 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 11.
5 of these are in force and held by Alexion Pharmaceuticals, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.